Transactions
Aspen concludes the acquisition of an API Business from MSD
01 October 2013 By : Shauneen Beukes 1 October 2013 Oss, the Netherlands – JSE
Filter By:
01 October 2013 By : Shauneen Beukes 1 October 2013 Oss, the Netherlands – JSE
Durban, South Africa: Aspen Global Incorporated (“AGI”), a wholly owned subsidiary of Aspen, announced today
Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), the ninth largest generic company
Johannesburg: Aspen Pharmacare, a JSE-listed leading pharmaceutical company in the southern hemisphere, provided a financial
Oss, Netherlands – JSE Limited listed Aspen Holdings is pleased to announce that the Aspen
APN – Aspen Pharmacare Holdings Limited – Trading statement Aspen Pharmacare Holdings Limited (Incorporated in
In addition to maintaining the supply contract for existing tender items, Aspen has also secured volumes for two new products, Aspen Efavirenz and Tenofivir. Tenofivir
Aspen Pharmacare Holdings Limited is pleased to announce the conclusion of a deal for the acquisition of 60% of the share capital of Shelys Africa
After my interview with him it once again dawned on me how important it is to enjoy what you do; to have a passion for
Johannesburg – JSE listed Aspen (Apn), Africa’s largest pharmaceutical manufacturer, has recorded consistently positive results for the period ended December 2007. Revenue increased by 15
Johannesburg South Africa, and Bangalore, India: Aspen Pharmacare (Aspen), Africa’s largest pharmaceutical manufacturer and the largest generics manufacturer in the southern hemisphere, has entered into
Johannesburg – JSE listed Aspen (Apn), Africa’s largest pharmaceutical manufacturer, has announced a sound set of results for the financial year ended June 30, 2007.
JSE listed Aspen (APN), Africa and the Southern hemisphere’s largest pharmaceutical manufacturer, has hosted the Honourable Minister Mosibudi Mangena, MP, South African Minister of Science
JSE listed Aspen, a leading global manufacturer and distributor of anti-retroviral (ARV) medicines, today announced that it has been granted certification from the Medicines Control
Aspen Holdings
www.aspenpharma.com
Hotline (South Africa)
0800 122 912
Medical Careline (South Africa) 0800 118 088
Shauneen Beukes
Group Communications Consultant
+27 31 580 8600
+27 82 389 8900
sbeukes@aspenpharma.com